For clinicians · Podcast
Cholesterol Conversations
Statins are the first-line therapy for lowering LDL-C and reducing ASCVD risk, yet many high-risk patients remain undertreated.
Listen to the latest episode
VLN’s Cholesterol Conversations podcast explores the latest ASCVD management guidance, treatment options for optimal LDL-C lowering, and emerging data on novel and combination therapies.
Latest episode · Cholesterol Conversations
Now What? Putting the 2026 Dyslipidemia Guidelines into Practice
October 1, 2026 · 25 min
0:0024:48
Every episode
4 episodes
Oct 1, 2026
Now What? Putting the 2026 Dyslipidemia Guidelines into Practice
Mar 30, 2025
Mastering LDL Management in 2025
Mar 8, 2023
How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals
Feb 21, 2023
ASCVD Management: Making the Case for Nonstatin Therapies
Never miss an episode
Follow the show wherever you listen, and get every new conversation the moment it drops.
